BETHESDA, Md--It's called "Know Your Options: The National Prostate Cancer Education Program," and it's a joint effort by the National Cancer Institute and US TOO International, the world's largest men's cancer group.
BETHESDA, Md--It's called "Know Your Options: The National ProstateCancer Education Program," and it's a joint effort by the NationalCancer Institute and US TOO International, the world's largest men's cancergroup.
The two organizations have taken aim at men age 50 and older, and those40 or over who are at high risk of prostate cancer, to increase their awarenessabout the detection, diagnosis, and management of the disease.
The effort will include multicity symposia for health professionalsand lay audiences, the development of interactive software to provide informationabout prostate cancer, and enhancement of US TOO's website (http://www.ustoo.com)to help men sort through the complexities of prostate cancer management.
Data Support Early Genetic Testing in HRR+ mCRPC Managed With Olaparib
January 27th 2024Testing for HRR status prior to a diagnosis of metastatic castration-resistant prostate cancer may allow for earlier treatment and potentially greater clinical benefit with olaparib, according to Daniel J. George, MD.